Excagol medtech is developing an automated venipuncture device that will take on the most common invasive activity in healthcare centers: EVA, the electronic venipuncture apparatus. Medical personnel can perform punctures efficiently, safely and stress-free with EVA, the mobile computer-controlled system. Vascular structures are made visible by ultrasonic waves. An image processing algorithm recognizes vessels and recommends a suitable target for puncture. After the operator’s confirmation, the needle is automatically steered and precisely puncture the target.
Excagol’s Vision is to become the healthcare industry’s next-generation solution for various puncture purposes for both patients with difficult-to-reach veins and medical personnel with different professional experience.
Venous access is the most common invasive medical procedure and the success rate is unacceptably low: Only about 75% of all venipunctures are successful at the first attempt, often three or more attempts are necessary.
Excagol aims to reduce the failure rate from 25% at the first attempt in the manual process to 5% in the automated process.
Excagol targets the global blood collection market. According to Grand View Research, the blood collection market reached USD 8.5 Billion in 2018 and is projected to reach USD 13.99 Billion by 2026, growing at a CAGR of 6.6%. Excagol targets the venipuncture product market which is projected to reach over USD 962.7 Million by 2026, growing at a CAGR of 3.2% from 2021 to 2026.
Thanks to Life Science Nord for publishing the following article about excagol: https://lifesciencenord.de/de/news/detail/excagol-medtech-stellt-sich-vor.html Life Science Nord begrüßt das Medtech-Start-up herzlich als neues Mitglied im Förderverein! Die excagol medtech ist ein Hamburger Start-up, …
The talk Netzer has given during the last interview about excagol:
We are excited to share that recently excagol have won second place among the startups presenting an innovative medical solution for an existing medical opportunity from Sheba Medical Center, the …
Excagol Medtech specialized in healthcare and medical technology is looking to raise capital for the development of EVA. EVA is a mobile solution for quick and precise venipuncture. EVA automatically …
An ex-vivo feasibility test about automated venipuncture function was successfully performed by our laboratory demonstrator. Excagol’s software application remoted the laboratory demonstrator through a wireless connection via a tablet and …
Thanks to Hamburg Startups and to the author Mathias Jäger for publishing the following article about Excagol trifft jede Vene Excagol trifft jede Vene Gibt es gute und schlechte Venen? …
Thanks to Healthcare Startups Deutschland for publishing the following article about Excagol https://healthcare-startups.de/location/exagol/ Excagol Da die intravenöse Venenpunktion oft zu Komplikationen führt, möchte Excagol ein mobiles und automatisiertes Venenpunktionsgerät herstellen, …
A Bachelor Thesis was successfully performed at Excagol Medtech in cooperation with the mechanical engineering faculty at the University of Applied Sciences in Hamburg – Germany
